1 | Representative(s) Reagan offered the following: |
2 |
|
3 | Amendment (with title amendment) |
4 | Remove everything after the enacting clause and insert: |
5 | Section 1. Subsections (7) through (17) of section |
6 | 550.2415, Florida Statutes, are amended to read: |
7 | 550.2415 Racing of animals under certain conditions |
8 | prohibited; penalties; exceptions.-- |
9 | (7) All moneys recovered for violations of this section |
10 | shall be kept in a separate fund to be deposited into the Pari- |
11 | mutuel Wagering Trust Fund and shall be used for research |
12 | relating to the medication of racing animals. Such recovered |
13 | moneys shall be supervised and used by the division to contract |
14 | with a reputable college or school of veterinary medicine or its |
15 | designee in accordance with this subsection. |
16 | (7)(8) Under no circumstances may any medication be |
17 | administered closer than 24 hours prior to the officially |
18 | scheduled post time of a race except as provided for in this |
19 | section. |
20 | (a) The division shall adopt rules setting conditions for |
21 | the use of furosemide to treat exercise-induced pulmonary |
22 | hemorrhage. |
23 | (b) The division shall adopt rules setting conditions for |
24 | the use of prednisolone sodium succinate, but under no |
25 | circumstances may furosemide or prednisolone sodium succinate be |
26 | administered closer than 4 hours prior to the officially |
27 | scheduled post time for the race. |
28 | (c) The division shall adopt rules setting conditions for |
29 | the use of phenylbutazone and synthetic corticosteroids; in no |
30 | case, except as provided in paragraph (b), shall these |
31 | substances be given closer than 24 hours prior to the officially |
32 | scheduled post time of a race. Oral corticosteroids are |
33 | prohibited except when prescribed by a licensed veterinarian and |
34 | reported to the division on forms prescribed by the division. |
35 | (d) Nothing in this section shall be interpreted to |
36 | prohibit the use of vitamins, minerals, or naturally occurring |
37 | substances so long as none exceeds the normal physiological |
38 | concentration in a race-day race day specimen. |
39 | (e) The division may, by rule, establish acceptable levels |
40 | of permitted medications and shall select the appropriate |
41 | biological specimens by which the administration of permitted |
42 | medication is monitored. |
43 | (8)(9)(a) Under no circumstances may any medication be |
44 | administered within 24 hours before the officially scheduled |
45 | post time of the race except as provided in this section. |
46 | (b) As an exception to this section, if the division first |
47 | determines that the use of furosemide, phenylbutazone, or |
48 | prednisolone sodium succinate in horses is in the best interest |
49 | of racing, the division may adopt rules allowing such use. Any |
50 | rules allowing the use of furosemide, phenylbutazone, or |
51 | prednisolone sodium succinate in racing must set the conditions |
52 | for such use. Under no circumstances may a rule be adopted which |
53 | allows the administration of furosemide or prednisolone sodium |
54 | succinate within 4 hours before the officially scheduled post |
55 | time for the race. Under no circumstances may a rule be adopted |
56 | which allows the administration of phenylbutazone or any other |
57 | synthetic corticosteroid within 24 hours before the officially |
58 | scheduled post time for the race. Any administration of |
59 | synthetic corticosteroids is limited to parenteral routes. Oral |
60 | administration of synthetic corticosteroids is expressly |
61 | prohibited. If this paragraph is unconstitutional, it is |
62 | severable from the remainder of this section. |
63 | (c) The division shall, by rule, establish acceptable |
64 | levels of permitted medications and shall select the appropriate |
65 | biological specimen by which the administration of permitted |
66 | medications is monitored. |
67 | (9)(10)(a) The division may conduct a postmortem |
68 | examination of any animal that is injured at a permitted |
69 | racetrack while in training or in competition and that |
70 | subsequently expires or is destroyed. The division may conduct a |
71 | postmortem examination of any animal that expires while housed |
72 | at a permitted racetrack, association compound, or licensed |
73 | kennel or farm. Trainers and owners shall be requested to comply |
74 | with this paragraph as a condition of licensure. |
75 | (b) The division may take possession of the animal upon |
76 | death for postmortem examination. The division may submit blood, |
77 | urine, other bodily fluid specimens, or other tissue specimens |
78 | collected during a postmortem examination for testing by the |
79 | division laboratory or its designee. Upon completion of the |
80 | postmortem examination, the carcass must be returned to the |
81 | owner or disposed of at the owner's option. |
82 | (10)(11) The presence of a prohibited substance in an |
83 | animal, found by the division laboratory in a bodily fluid |
84 | specimen collected during the postmortem examination of the |
85 | animal, which breaks down during a race constitutes a violation |
86 | of this section. |
87 | (11)(12) The cost of postmortem examinations, testing, and |
88 | disposal must be borne by the division. |
89 | (12)(13) The division shall adopt rules to implement this |
90 | section. The rules may include a classification system for |
91 | prohibited substances and a corresponding penalty schedule for |
92 | violations. |
93 | (13)(14) Except as specifically modified by statute or by |
94 | rules of the division, the Uniform Classification Guidelines for |
95 | Foreign Substances, revised February 14, 1995, as promulgated by |
96 | the Association of Racing Commissioners International, Inc., is |
97 | hereby adopted by reference as the uniform classification system |
98 | for class IV and V medications. |
99 | (14)(15) The division shall utilize only the thin layer |
100 | chromatography (TLC) screening process to test for the presence |
101 | of class IV and V medications in samples taken from racehorses |
102 | except when thresholds of a class IV or class V medication have |
103 | been established and are enforced by rule. Once a sample has |
104 | been identified as suspicious for a class IV or class V |
105 | medication by the TLC screening process, the sample will be sent |
106 | for confirmation by and through additional testing methods. All |
107 | other medications not classified by rule as a class IV or class |
108 | V agent shall be subject to all forms of testing available to |
109 | the division. |
110 | (16) The division shall implement by rule medication |
111 | levels finalized by the University of Florida developed pursuant |
112 | to the Pharmacokinetic and Clearance Study Agreement by and |
113 | between the Florida Department of Business and Professional |
114 | Regulation Division of Pari-mutuel Wagering and the University |
115 | of Florida College of Veterinary Medicine. Research on a drug |
116 | level is finalized when the University of Florida College of |
117 | Veterinary Medicine provides written notification to the |
118 | division that it has completed its research on a particular drug |
119 | pursuant to the agreement and when the College of Veterinary |
120 | Medicine provides a final report of its findings, conclusions, |
121 | and recommendations to the division. |
122 | (15)(17) The testing medium for phenylbutazone in horses |
123 | shall be serum, and the division may collect up to six full 15- |
124 | milliliter blood tubes for each horse being sampled. |
125 | Section 2. Section 1011.93, Florida Statutes, is repealed. |
126 | Section 3. This act shall take effect upon becoming a law. |
127 |
|
128 |
|
129 | ======= T I T L E A M E N D M E N T ========== |
130 | Remove the entire title and insert: |
131 | A bill to be entitled |
132 | An act relating to research funded by pari-mutuel |
133 | wagering; amending s. 550.2415, F.S.; deleting provisions |
134 | for certain moneys to be used for research relating to the |
135 | medication of racing animals; deleting provisions relating |
136 | to the Pharmacokinetic and Clearance Study Agreement by |
137 | and between the Department of Business and Professional |
138 | Regulation Division of Pari-mutuel Wagering and the |
139 | University of Florida College of Veterinary Medicine; |
140 | repealing s. 1011.93, F.S., relating to research and |
141 | development programs funded by moneys in the Pari-mutuel |
142 | Wagering Trust Fund; providing an effective date. |